2016
DOI: 10.3892/etm.2016.3587
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the effects of ketamine on spinal anesthesia with levobupivacaine or ropivacaine

Abstract: Abstract. Spinal anesthesia or regional anesthesia is a potent anesthetic procedure. Additional modalities have been sought to increase the duration of block in spinal anesthesia. Ketamine is an N-methyl-D-aspartate (NMDA) receptor blocker that has an anesthetic effect when injected intrathecally and has a synergic effect with bupivacaine. Ketamine also has potent analgesic properties. The present study investigated the effect of intrathecally administered ketamine on spinal anesthesia with levobupivacaine or … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
2
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 61 publications
0
2
0
Order By: Relevance
“…This method requires catheterization of the subarachnoid space. The catheter insertion could be performed through the atlanto-occipital membrane [ 56 ] or at the junction of the L5 and L6 lumbar vertebrae [ 57 ] under general inhalation [ 58 ] or injection anesthesia [ 59 ].…”
Section: Resultsmentioning
confidence: 99%
“…This method requires catheterization of the subarachnoid space. The catheter insertion could be performed through the atlanto-occipital membrane [ 56 ] or at the junction of the L5 and L6 lumbar vertebrae [ 57 ] under general inhalation [ 58 ] or injection anesthesia [ 59 ].…”
Section: Resultsmentioning
confidence: 99%
“…Ketamine is an N-methyl-D-aspartate (NMDA) antagonist and has strong analgesic effects ( 6 ), which can be attributed to its effect on a number of opioid, muscarinic, and NMDA receptors ( 7 ). Administering ketamine with ropivacaine or levobupivacaine increases the intensity and duration of spinal anesthesia ( 6 ). Dexmedetomidine is an alpha-2 receptor agonist whose analgesic effect seems to be related to the release of acetylcholine.…”
Section: Introductionmentioning
confidence: 99%
“…It is reported to be the most myotoxic local anesthetic available and is associated with notable cardiotoxic and neurotoxic effects. [5][6][7] Existing medical literature has explored intravenous lipid emulsions and cerebrospinal fluid (CSF) exchange as potential strategies to counteract the undesirable effects of a high or total spinal block. Although the symptoms of sympathectomy manifest rapidly, current treatment approaches tend to be limited in their application and often exhibit a delayed onset of action.…”
Section: Introductionmentioning
confidence: 99%